Hypertension, coronary heart disease and stroke: Should the blood pressure J-curve be a concern?;Hipertensão arterial, doença coronária e acidente vascular cerebral. A curva em J deve preocupar-nos?

Revista Portuguesa de Cardiologia

Volumn 32, Issue 2, 2013, Pages 139-144

  Nogueira, José Braz ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Coronary heart disease; Hypertension; J curve; Stroke

Indexed keywords

CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 84876067578     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repc.2012.06.008     Document Type: Short Survey

References (44)

1. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-13.
2. Stewart IM. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet. 1979;1:861-5.
3. Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet. 1987;1:581-4.
4. Cruickshank JM. Coronary flow and the J-curve relation between diastolic blood pressure and myocardial infarction. Br Med J. 1988;297:1227-30. (Pubitemid 18259761)
5. D'Agostino RB, Belanger AJ, Kannel WB, et al. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study. BMJ. 1991;303:385-9.
6. Farnett L, Mulrow CD, Linn WD, et al. The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? JAMA. 1991;265:489-95.
7. Voko Z, Bots ML, Hofman A, et al. J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension. 1999;34:1181-5. (Pubitemid 30002379)
8. Arima H, Chalmers J, Woodward M, et al. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens. 2006;24:1201-8. (Pubitemid 43772329)
9. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke. 2003;34:2471-8.
10. Turan TN, Cotsonis G, Lynn MJ, et al., for the Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) trial investigators. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation. 2007;115:2969-75. (Pubitemid 46912100)
11. Reboldi G, Gentile G, Angeli F, et al. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients. J Hypertens. 2011;29:1253-69.
12. Kannel WB, Wilson PW, Nam BH, et al. A likely explanation for J-curve of blood pressure cardiovascular risk. Am J Cardiol. 2004;94:380-4. (Pubitemid 38962714)
13. Somes GW, Pahor M, Shorr RI, et al. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med. 1999;159:2004-9. (Pubitemid 29453587)
14. Boutitie F, Gueyffier F, Pocock S, et al. J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med. 2002;136:438-48. (Pubitemid 34234783)
15. Hanson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351:1755-6.
16. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-13.
17. Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27:2121-58.
18. Arguedas JA, Perez MI, Wright JM. Treatment blood pressure targets for hypertension. Cochrane Database of Systematic Reviews. 2009;3:1-28.
19. ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370:829-40.
20. ACCORD Study Group, Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575-85.
21. Bangalore S, Kumar S, Lobach I, et al. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional Bayesian random-effects meta-analyses of randomized trials. Circulation. 2011;123:2799-810.
22. Cooper-DeHoff RM, Gong Y, Handberg EM, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010;304:61-8.
23. Beckett NS, Peters R, Fletcher AE, et al., HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887-98. (Pubitemid 351620109)
24. Ogihara T, Saruta T, Rakugi H, et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly. Hypertension. 2010;56:196-202.
25. Jatos Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008;31:2115-27.
26. Messerli FH, Mancia G, Conti CR, et al. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 2006;144:884-93. (Pubitemid 46768128)
27. Denardo SJ, Gong Y, Nichols WW, et al. Blood pressure and outcomes in Very Old Hypertensive Coronary Artery Disease Patients: an INVEST substudy. Am J Med. 2010;123:719-26.
28. Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363:2022-31. (Pubitemid 38781102)
29. Fagard RH, Staessen JA, Thijs L, et al. On-treatment diastolic blood pressure and prognosis in systolic hypertension. Arch Intern Med. 2007;167:1884-91. (Pubitemid 47481484)
30. Cruickshank JM. Antihypertensive treatment and the J-curve. Cardiovasc Drugs Ther. 2000;14:373-9. (Pubitemid 30663719)
31. Bangalore S, Messerli FH, Wun CC, et al. J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. Eur Heart J. 2010;31:2897-908.
32. Sleight P, Redon J, Verdecchia P, et al., ONTARGET investigators. Prognostic value of blood pressure in patients with vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial Study. J Hypertens. 2009;27:1360-9.
33. Redon J, Mancia G, Sleight P, et al., ONTARGET investigators. Safety and efficacy of low blood pressures among patients with diabetes, subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial). J Am Coll Cardiol. 2012;59:74-83.
34. Anderson RJ, Bahn GD, Moritz TE, et al., VADT Study Group. Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial. Diabetes Care. 2011;34:34-8.
35. Banglore S, Qin J, Sloan S, et al. What is the optimal blood pressure in patients after acute coronary syndromes? Relationship of blood pressure and cardiovascular events in the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction (PROVE IT-TIMI) 22 Trial. Circulation. 2010;122:2142-51.
36. Dorresteijn JAN, Van der Graaf Y, Spiering W, et al. Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease. J curve revisited Hypertension. 2012;59:14-21.
37. Sandst EC, Bath PM, Boysen G, et al., SCAST Study Group. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet. 2011;377:741-50.
38. Ovbiagele B, Diener HC, Yusuf S, et al., PROFESS investigators. Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA. 2011;306:2137-44.
39. Chrysant SG, Chrysant GS. Effectiveness of lowering blood pressure to prevent stroke versus to prevent coronary events. Am J Cardiol. 2010;106:825-9.
40. Williams B. Hypertension and the J-Curve. JACC. 2009;54:1835-6.
41. Kaplan NM. The diastolic J curve. Alive and threatening. Hypertension. 2011;58:751-3.
42. Chrysant SG. Current status of aggressive blood pressure control. World J Cardiol. 2011;3:65-71.
43. Flynn C, Bakris GL. Blood pressure targets for patients with diabetes or kidney disease. Curr Hypertens Rep. 2011;13:452-5.
44. Nilsson PM. Target blood pressure in diabetes patients with hypertension - what is the accumulated evidence in 2011? J Zhejiang Univ-SCi B (Biomed & Biotechnol). 2011;12:611-23.